Your session is about to expire
← Back to Search
LGBTQ-Inclusive Care Training for Alzheimer's Disease (MILLS Trial)
MILLS Trial Summary
This trial will test whether training the long-term care workforce in sexual and gender minority culturally responsive care improves care for patients with Alzheimer's Disease and Alzheimer's Disease Related Dementia.
MILLS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MILLS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing to review policies and environment now and in 6 months.
- Group 1: Training to Serve online training (eTTS)
- Group 2: Training to Serve (TTS) in person training
- Group 3: Waitlist control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the research team currently recruiting volunteers?
"As reported on clinicaltrials.gov, this medical study is no longer actively looking to accept patients. Initially posted in October of 2023, the last update was registered during September 2022. Despite this trial being inactive at present, there are 764 other studies that have open enrolment for participants."
What are the prime goals of this experiment?
"This clinical trial intends to measure Skills assessment over a baseline period and 6-month follow up. Additional objectives include ascertaining Health care empathy using the Jefferson Physician Empathy student version, SGM knowledge with a 10-item review of key content in training, and evaluating SGM attitudes through employment of the Homonegativity scale."
Share this study with friends
Copy Link
Messenger